Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen

NCT00324610 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Chemotherapy

Interventions

DRUG: capecitabine

Sponsor

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie